Edition:
United States

Takeda Pharmaceutical Co Ltd (4502.T)

4502.T on Tokyo Stock Exchange

3,771JPY
10 Dec 2018
Change (% chg)

-- (--)
Prev Close
¥3,771
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
5,835,579
52-wk High
¥6,693
52-wk Low
¥3,761

Select another date:

Wed, Dec 5 2018

Photo

Takeda clears key hurdle as investors back $59 billion Shire deal

OSAKA Takeda Pharmaceutical has won shareholder approval for its $59 billion takeover of London-listed Shire , creating a global powerhouse that has a stronger drugs pipeline but is also saddled with massive debt. | Video

UPDATE 4-Takeda clears key hurdle as investors back $59 billion Shire deal

* Shares in Shire and Takeda both gain ground (Updates with approval from Shire shareholders)

Takeda shareholders approve Shire acquisition - spokesman

TOKYO, Dec 5 Takeda Pharmaceutical shareholders approved on Wednesday its $59 billion takeover of London-listed Shire, a Takeda spokesman said, creating a global powerhouse with a stronger drugs pipeline but one that is saddled with massive debt.

EU approves Takeda buying Shire, on divestment condition

BRUSSELS The European Commission said on Tuesday that it approved the $62-billion takeover of London's Shire plc by Takeda Pharmaceutical of Japan, subject to the divestment of a Shire drug in development.

EU approves Takeda buying Shire, on divestment condition

BRUSSELS, Nov 20 The European Commission said on Tuesday that it approved the $62-billion takeover of London's Shire plc by Takeda Pharmaceutical of Japan, subject to the divestment of a Shire drug in development.

Investor advisory firms back Takeda's $62 billion deal for Shire

LONDON Two shareholder advisory firms have backed Takeda Pharmaceutical's $62 billion takeover offer for drugmaker Shire , dealing a blow to a group of investors who hope to block the deal.

Investor advisory firms back Takeda's $62 billion deal for Shire

LONDON, Nov 20 Two shareholder advisory firms have backed Takeda Pharmaceutical's $62 billion takeover offer for drugmaker Shire, dealing a blow to a group of investors who hope to block the deal.

Takeda's Shire takeover to bring $963 million fee bonanza

LONDON Banks, law firms and other advisers stand to earn up to $963 million in fees from Takeda Pharmaceutical's $62 billion takeover of drugmaker Shire , according to documents for the deal published on Monday.

Takeda's Shire takeover to bring $963 million fee bonanza

LONDON, Nov 12 Banks, law firms and other advisers stand to earn up to $963 million in fees from Takeda Pharmaceutical's $62 billion takeover of drugmaker Shire, according to documents for the deal published on Monday.

Takeda sets vote date, aims to close $62 billion Shire deal Jan. 8

LONDON Japan's Takeda Pharmaceutical will hold an investor vote on its $62 billion acquisition of Shire next month and aims to close the deal on Jan. 8, signaling its confidence in securing the required support.

Select another date: